CD155 and its receptors in cancer immune escape and immunotherapy

R Zhou, S Chen, Q Wu, L Liu, Y Wang, Y Mo, Z Zeng… - Cancer letters, 2023 - Elsevier
In recent years, there have been multiple breakthroughs in cancer immunotherapy, with
immune checkpoint inhibitors becoming the most promising treatment strategy. However …

[HTML][HTML] Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy

W Zhang, Z Zhao, F Li - Molecular Immunology, 2022 - Elsevier
The continuous, in-depth exploration of the occurrence and development of cancer has
shown that immune cell dysfunction is closely associated with tumor progression and poor …

A ferroptosis-related gene prognostic index associated with biochemical recurrence and radiation resistance for patients with prostate cancer undergoing radical …

D Feng, X Shi, Q Xiong, F Zhang, D Li… - Frontiers in Cell and …, 2022 - frontiersin.org
Background: Ferroptosis is a new type of programmed cell death which has been reported to
be involved in the development of various cancers. In this study, we attempted to explore the …

N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer

J Wu, X Wang, X Li - Epigenomics, 2022 - Taylor & Francis
Aims: This study aimed to reveal the possible molecular mechanism of n6-methyladenosine
(m6A) methylation regulator FTO in the biological activities of ovarian cancer (OC) based on …

CD96 as a potential immune regulator in cancers

S Feng, O Isayev, J Werner, AV Bazhin - International journal of molecular …, 2023 - mdpi.com
The discovery of CTLA-4 and PD-1 checkpoints has prompted scientific researchers and the
pharmaceutical industry to develop and conduct extensive research on tumor-specific …

Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives

P Farhangnia, M Akbarpour, M Yazdanifar… - Expert Review of …, 2022 - Taylor & Francis
Introduction The development of therapeutic antibodies targeting immune checkpoint
molecules (ICMs) that induce long-term remissions in cancer patients has revolutionized …

CD155 and its receptors as targets for cancer therapy

R Paolini, R Molfetta - International Journal of Molecular Sciences, 2023 - mdpi.com
CD155, also known as the poliovirus receptor, is an adhesion molecule often overexpressed
in tumors of different origins where it promotes cell migration and proliferation. In addition to …

From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review

M Regmi, Y Wang, W Liu, Y Dai, S Liu, K Ma… - Journal of Experimental …, 2024 - Springer
In tumor therapeutics, the transition from conventional cytotoxic drugs to targeted molecular
therapies, such as those targeting receptor tyrosine kinases, has been pivotal. Despite this …

Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma

J Liu, Z Zhou, L Ma, C Li, Y Lin, T Yu, JF Wei… - Cancer Cell …, 2021 - Springer
Background Melanoma is an extremely aggressive type of skin cancer and experiencing a
expeditiously rising mortality in a current year. Exploring new potential prognostic …

Screening of potential immune-related genes expressed during sepsis using gene sequencing technology

Y Tian, C Wang, Q Lu, C Zhang, L Hu, J Ling… - Scientific Reports, 2023 - nature.com
To screen potential pivotal targets in sepsis through peripheral blood. Septic patients (n= 23)
and healthy volunteers (n= 10) were enrolled according to SEPSIS 3.0. Peripheral blood …